<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30635658</PMID><DateCompleted><Year>2021</Year><Month>01</Month><Day>07</Day></DateCompleted><DateRevised><Year>2021</Year><Month>01</Month><Day>11</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1476-5470</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Jan</Month></PubDate></JournalIssue><Title>Genes and immunity</Title><ISOAbbreviation>Genes Immun</ISOAbbreviation></Journal><ArticleTitle>Mother-child histocompatibility and risk of rheumatoid arthritis and systemic lupus erythematosus among mothers.</ArticleTitle><Pagination><StartPage>27</StartPage><EndPage>36</EndPage><MedlinePgn>27-36</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41435-018-0055-7</ELocationID><Abstract><AbstractText>The study objective was to test the hypothesis that having histocompatible children increases the risk of rheumatoid arthritis (RA) and systemic lupus erythematosus (SLE), possibly by contributing to the persistence of fetal cells acquired during pregnancy. We conducted a case control study using data from the UC San Francisco Mother Child Immunogenetic Study and studies at the Inova Translational Medicine Institute. We imputed human leukocyte antigen (HLA) alleles and minor histocompatibility antigens (mHags). We created a variable of exposure to histocompatible children. We estimated an average sequence similarity matching (SSM) score for each mother based on discordant mother-child alleles as a measure of histocompatibility. We used logistic regression models to estimate odds ratios (ORs) and 95% confidence intervals. A total of 138 RA, 117 SLE, and 913 control mothers were analyzed. Increased risk of RA was associated with having any child compatible at HLA-B (OR 1.9; 1.2-3.1), DPB1 (OR 1.8; 1.2-2.6) or DQB1 (OR 1.8; 1.2-2.7). Compatibility at mHag ZAPHIR was associated with reduced risk of SLE among mothers carrying the HLA-restriction allele B*07:02 (n&#x2009;=&#x2009;262; OR 0.4; 0.2-0.8). Our findings support the hypothesis that mother-child histocompatibility is associated with risk of RA and SLE.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Cruz</LastName><ForeName>Giovanna I</ForeName><Initials>GI</Initials><AffiliationInfo><Affiliation>Genetic Epidemiology and Genomics Lab, Division of Epidemiology, School of Public Health, University of California Berkeley, 324 Stanley Hall, Berkeley, CA, 94720-3220, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Shao</LastName><ForeName>Xiaorong</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Genetic Epidemiology and Genomics Lab, Division of Epidemiology, School of Public Health, University of California Berkeley, 324 Stanley Hall, Berkeley, CA, 94720-3220, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quach</LastName><ForeName>Hong</ForeName><Initials>H</Initials><AffiliationInfo><Affiliation>Genetic Epidemiology and Genomics Lab, Division of Epidemiology, School of Public Health, University of California Berkeley, 324 Stanley Hall, Berkeley, CA, 94720-3220, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quach</LastName><ForeName>Diana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Genetic Epidemiology and Genomics Lab, Division of Epidemiology, School of Public Health, University of California Berkeley, 324 Stanley Hall, Berkeley, CA, 94720-3220, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ho</LastName><ForeName>Kimberly A</ForeName><Initials>KA</Initials><AffiliationInfo><Affiliation>Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, Department of Medicine, University of California San Francisco, San Francisco, CA, 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sterba</LastName><ForeName>Kirsten</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, Department of Medicine, University of California San Francisco, San Francisco, CA, 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Noble</LastName><ForeName>Janelle A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Children's Hospital Oakland Research Institute, 5700 M.L.K. Jr. Way, Oakland, CA, 94609, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patsopoulos</LastName><ForeName>Nikolaos A</ForeName><Initials>NA</Initials><AffiliationInfo><Affiliation>Division of Genetics, Department of Medicine, Brigham &amp; Women's Hospital, Harvard Medical School, 77 Avenue Louis Pasteur, Boston, MA, 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Translational Neuropsychiatric Genomics, Institute for the Neurosciences, Department of Neurology, Brigham &amp; Women's Hospital, 75 Francis Street, Boston, MA, 02115, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Program in Medical and Population Genetics, Broad Institute of Massachusetts Institute of Technology and Harvard, 415 Main Street, Cambridge, MA, 02142, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Busch</LastName><ForeName>Michael P</ForeName><Initials>MP</Initials><AffiliationInfo><Affiliation>Blood Systems Research Institute, 270 Masonic Avenue, San Francisco, CA, 94118-4417, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Triulzi</LastName><ForeName>Darrell J</ForeName><Initials>DJ</Initials><AffiliationInfo><Affiliation>Institute for Transfusion Medicine, Department of Pathology, University of Pittsburgh, 3636 Blvd. of the Allies, Pittsburgh, PA, 15213, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ladas</LastName><ForeName>Nektarios</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blasczyk</LastName><ForeName>Rainer</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Institute for Transfusion Medicine, Hannover Medical School, Hannover, Germany.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wong</LastName><ForeName>Wendy S W</ForeName><Initials>WSW</Initials><Identifier Source="ORCID">0000-0001-9850-3797</Identifier><AffiliationInfo><Affiliation>Division of Medical Genomics, Inova Translational Medicine Institute, 8110 Gatehouse Road, Falls Church, VA, 22042, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Solomon</LastName><ForeName>Benjamin D</ForeName><Initials>BD</Initials><AffiliationInfo><Affiliation>Division of Medical Genomics, Inova Translational Medicine Institute, 8110 Gatehouse Road, Falls Church, VA, 22042, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Niederhuber</LastName><ForeName>John E</ForeName><Initials>JE</Initials><AffiliationInfo><Affiliation>Division of Medical Genomics, Inova Translational Medicine Institute, 8110 Gatehouse Road, Falls Church, VA, 22042, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, Johns Hopkins University, Baltimore, MD, 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Criswell</LastName><ForeName>Lindsey A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Rosalind Russell/Ephraim P. Engleman Rheumatology Research Center, Department of Medicine, University of California San Francisco, San Francisco, CA, 94143, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barcellos</LastName><ForeName>Lisa F</ForeName><Initials>LF</Initials><AffiliationInfo><Affiliation>Genetic Epidemiology and Genomics Lab, Division of Epidemiology, School of Public Health, University of California Berkeley, 324 Stanley Hall, Berkeley, CA, 94720-3220, USA. lbarcellos@berkeley.edu.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>California Institute for Quantitative Biosciences (QB3), University of California Berkeley, 174 Stanley Hall, Berkeley, CA, 94720-3220, USA. lbarcellos@berkeley.edu.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R21 AI117879</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI059829</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AI065841</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P30 AR070155</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 AR052300</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>P60 AR053308</GrantID><Acronym>AR</Acronym><Agency>NIAMS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AR044804</GrantID><Agency>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)</Agency><Country>International</Country></Grant><Grant><GrantID>M01 RR000079</GrantID><Acronym>RR</Acronym><Agency>NCRR NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01AR052300</GrantID><Agency>U.S. Department of Health &amp;amp; Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID)</Agency><Country>International</Country></Grant><Grant><GrantID>F31 AI116064</GrantID><Acronym>AI</Acronym><Agency>NIAID NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>01</Month><Day>12</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Genes Immun</MedlineTA><NlmUniqueID>100953417</NlmUniqueID><ISSNLinking>1466-4879</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015235">HLA-B Antigens</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D059866">HLA-DQ beta-Chains</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C057615">HLA-DQbeta antigen</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D015395">Histocompatibility Antigens Class I</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000483" MajorTopicYN="N">Alleles</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D001172" MajorTopicYN="N">Arthritis, Rheumatoid</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016022" MajorTopicYN="N">Case-Control Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005787" MajorTopicYN="N">Gene Frequency</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020022" MajorTopicYN="N">Genetic Predisposition to Disease</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015235" MajorTopicYN="N">HLA-B Antigens</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D059866" MajorTopicYN="N">HLA-DQ beta-Chains</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006648" MajorTopicYN="N">Histocompatibility</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015395" MajorTopicYN="N">Histocompatibility Antigens Class I</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="N">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="Y">etiology</QualifierName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009035" MajorTopicYN="N">Mothers</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016017" MajorTopicYN="N">Odds Ratio</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011247" MajorTopicYN="N">Pregnancy</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare that they have no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>5</Month><Day>28</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>10</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>1</Month><Day>8</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>1</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30635658</ArticleId><ArticleId IdType="pmc">PMC7039805</ArticleId><ArticleId IdType="doi">10.1038/s41435-018-0055-7</ArticleId><ArticleId IdType="pii">10.1038/s41435-018-0055-7</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Fernando MM, Stevens CR, Walsh EC, De Jager PL, Goyette P, Plenge RM, et al. Defining the role of the MHC in autoimmunity: a review and pooled analysis. PLoS Genet. 2008;4:e1000024.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2291482</ArticleId><ArticleId IdType="pubmed">18437207</ArticleId></ArticleIdList></Reference><Reference><Citation>McCombe PA, Greer JM, Mackay IR. Sexual dimorphism in autoimmune disease. Curr Mol Med. 2009;9:1058&#x2013;79.</Citation><ArticleIdList><ArticleId IdType="pubmed">19747114</ArticleId></ArticleIdList></Reference><Reference><Citation>Cooper GS, Stroehla BC. The epidemiology of autoimmune diseases. Autoimmun Rev. 2003;2:119&#x2013;25.</Citation><ArticleIdList><ArticleId IdType="pubmed">12848952</ArticleId></ArticleIdList></Reference><Reference><Citation>Hench PS. The amelioration effect of pregnancy on chronic atrophic (infectious) arthritis, fibrosis and intermittten hydrarthrosis. Mayo Clin Proc. 1938;13:7.</Citation></Reference><Reference><Citation>de Man YA, Dolhain RJ, van de Geijn FE, Willemsen SP, Hazes JM. Disease activity of rheumatoid arthritis during pregnancy: results from a nationwide prospective study. Arthritis Rheum. 2008;59:1241&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">18759316</ArticleId></ArticleIdList></Reference><Reference><Citation>Doria A, Cutolo M, Ghirardello A, Zampieri S, Vescovi F, Sulli A, et al. Steroid hormones and disease activity during pregnancy in systemic lupus erythematosus. Arthritis Rheum. 2002;47:202&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">11954015</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruiz-Irastorza G, Lima F, Alves J, Khamashta MA, Simpson J, Hughes GR, et al. Increased rate of lupus flare during pregnancy and the puerperium: a prospective study of 78 pregnancies. Br J Rheumatol. 1996;35:133&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">8612024</ArticleId></ArticleIdList></Reference><Reference><Citation>Silman A, Kay A, Brennan P. Timing of pregnancy in relation to the onset of rheumatoid arthritis. Arthritis Rheum. 1992;35:152&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pubmed">1734904</ArticleId></ArticleIdList></Reference><Reference><Citation>Orellana C, Wedren S, Kallberg H, Holmqvist M, Karlson EW, Alfredsson L, et al. Parity and the risk of developing rheumatoid arthritis: results from the Swedish Epidemiological Investigation of Rheumatoid Arthritis study. Ann Rheum Dis. 2014;73:752&#x2013;5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4086877</ArticleId><ArticleId IdType="pubmed">23887288</ArticleId></ArticleIdList></Reference><Reference><Citation>Wallenius M, Skomsvoll JF, Irgens LM, Salvesen KA, Koldingsnes W, Mikkelsen K, et al. Postpartum onset of rheumatoid arthritis and other chronic arthritides: results from a patient register linked to a medical birth registry. Ann Rheum Dis. 2010;69:332&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">19717397</ArticleId></ArticleIdList></Reference><Reference><Citation>Ulff-Moller CJ, Jorgensen KT, Pedersen BV, Nielsen NM, Frisch M. Reproductive factors and risk of systemic lupus erythematosus: nationwide cohort study in Denmark. J Rheumatol. 2009;36:1903&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">19567628</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson JL, Hughes KA, Smith AG, Nisperos BB, Branchaud AM, Hansen JA. Maternal-fetal disparity in HLA class II alloantigens and the pregnancy-induced amelioration of rheumatoid arthritis. N Engl J Med. 1993;329:466&#x2013;71.</Citation><ArticleIdList><ArticleId IdType="pubmed">8332151</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Horst-Bruinsma IE, de Vries RR, de Buck PD, van Schendel PW, Breedveld FC, Schreuder GM, et al. Influence of HLA-class II incompatibility between mother and fetus on the development and course of rheumatoid arthritis of the mother. Ann Rheum Dis. 1998;57:286&#x2013;90.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1752598</ArticleId><ArticleId IdType="pubmed">9741312</ArticleId></ArticleIdList></Reference><Reference><Citation>Zrour SH, Boumiza R, Sakly N, Mannai R, Korbaa W, Younes M, et al. The impact of pregnancy on rheumatoid arthritis outcome: the role of maternofetal HLA class II disparity. Jt, Bone, Spine : Rev du Rhum. 2010;77:36&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">20031464</ArticleId></ArticleIdList></Reference><Reference><Citation>Kekow M, Barleben M, Drynda S, Jakubiczka S, Kekow J, Brune T. Long-term persistence and effects of fetal microchimerisms on disease onset and status in a cohort of women with rheumatoid arthritis and systemic lupus erythematosus. BMC Musculoskelet Disord. 2013;14:325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3835618</ArticleId><ArticleId IdType="pubmed">24245522</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson JL. Maternal-fetal immunology and autoimmune disease: is some autoimmune disease auto-alloimmune or allo-autoimmune? Arthritis Rheum. 1996;39:191&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">8849367</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersdorf EW. The major histocompatibility complex: a model for understanding graft-versus-host disease. Blood. 2013;122:1863&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3772496</ArticleId><ArticleId IdType="pubmed">23878143</ArticleId></ArticleIdList></Reference><Reference><Citation>Spierings E, Kim YH, Hendriks M, Borst E, Sergeant R, Canossi A, et al. Multicenter analyses demonstrate significant clinical effects of minor histocompatibility antigens on GvHD and GvL after HLA-matched related and unrelated hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2013;19:1244&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">23756210</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffioen M, van Bergen CA, Falkenburg JH. Autosomal minor histocompatibility antigens: how genetic variants create diversity in immune targets. Front Immunol. 2016;7:100.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4791598</ArticleId><ArticleId IdType="pubmed">27014279</ArticleId></ArticleIdList></Reference><Reference><Citation>Valenta LJ, Elias AN. Familial scleroderma in a kindred with high incidence of autoimmune disease: correlation with HLA-A1/B8 haplotype. Arch Dermatol. 1987;123:1438&#x2013;40.</Citation><ArticleIdList><ArticleId IdType="pubmed">3499864</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson JL. HLA relationships of pregnancy, microchimerism and autoimmune disease. J Reprod Immunol. 2001;52:77&#x2013;84.</Citation><ArticleIdList><ArticleId IdType="pubmed">11600179</ArticleId></ArticleIdList></Reference><Reference><Citation>van der Woude D, Rantapaa-Dahlqvist S, Ioan-Facsinay A, Onnekink C, Schwarte CM, Verpoort KN, et al. Epitope spreading of the anti-citrullinated protein antibody response occurs before disease onset and is associated with the disease course of early arthritis. Ann Rheum Dis. 2010;69:1554&#x2013;61.</Citation><ArticleIdList><ArticleId IdType="pubmed">20448290</ArticleId></ArticleIdList></Reference><Reference><Citation>Schumacher A, Wafula PO, Bertoja AZ, Sollwedel A, Thuere C, Wollenberg I, et al. Mechanisms of action of regulatory T cells specific for paternal antigens during pregnancy. Obstet Gynecol. 2007;110:1137&#x2013;45.</Citation><ArticleIdList><ArticleId IdType="pubmed">17978130</ArticleId></ArticleIdList></Reference><Reference><Citation>Ostensen M, Villiger PM, Forger F. Interaction of pregnancy and autoimmune rheumatic disease. Autoimmun Rev. 2012;11:A437&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">22154710</ArticleId></ArticleIdList></Reference><Reference><Citation>Jara LJ, Medina G, Cruz-Dominguez P, Navarro C, Vera-Lastra O, Saavedra MA. Risk factors of systemic lupus erythematosus flares during pregnancy. Immunol Res. 2014;60:184&#x2013;92.</Citation><ArticleIdList><ArticleId IdType="pubmed">25391611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim MY, Guerra MM, Kaplowitz E, Laskin CA, Petri M, Branch DW, et al. Complement activation predicts adverse pregnancy outcome in patients with systemic lupus erythematosus and/or antiphospholipid antibodies. Ann Rheum Dis. 2018;77:549&#x2013;55.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6037302</ArticleId><ArticleId IdType="pubmed">29371202</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson JL, Furst DE, Maloney S, Gooley T, Evans PC, Smith A, et al. Microchimerism and HLA-compatible relationships of pregnancy in scleroderma. Lancet. 1998;351:559&#x2013;62.</Citation><ArticleIdList><ArticleId IdType="pubmed">9492775</ArticleId></ArticleIdList></Reference><Reference><Citation>Bronson PG, Komorowski LK, Ramsay PP, May SL, Noble J, Lane JA, et al. Analysis of maternal-offspring HLA compatibility, parent-of-origin effects, and noninherited maternal antigen effects for HLA-DRB1 in systemic lupus erythematosus. Arthritis Rheum. 2010;62:1712&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2948464</ArticleId><ArticleId IdType="pubmed">20191587</ArticleId></ArticleIdList></Reference><Reference><Citation>Broen K, Levenga H, Vos J, van Bergen K, Fredrix H, Greupink-Draaisma A, et al. A polymorphism in the splice donor site of ZNF41 9 results in the novel renal cell carcinoma-associated minor histocompatibility antigen ZAPHIR. PLoS ONE. 2011;6:e21699.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3125305</ArticleId><ArticleId IdType="pubmed">21738768</ArticleId></ArticleIdList></Reference><Reference><Citation>Arroyo JP, Gamba G. Advances in WNK signaling of salt and potassium metabolism: clinical implications. Am J Nephrol. 2012;35:379&#x2013;86.</Citation><ArticleIdList><ArticleId IdType="pubmed">22508439</ArticleId></ArticleIdList></Reference><Reference><Citation>Arkema EV, Palmsten K, Sjowall C, Svenungsson E, Salmon JE, Simard JF. What to expect when expecting with systemic lupus erythematosus (SLE): a population-based study of maternal and fetal outcomes in SLE and pre-SLE. Arthritis Care Res. 2016;68:988&#x2013;94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5094783</ArticleId><ArticleId IdType="pubmed">27338103</ArticleId></ArticleIdList></Reference><Reference><Citation>Kochl R, Thelen F, Vanes L, Brazao TF, Fountain K, Xie J, et al. WNK1 kinase balances T cell adhesion versus migration in vivo. Nat Immunol. 2016;17:1075&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4994873</ArticleId><ArticleId IdType="pubmed">27400149</ArticleId></ArticleIdList></Reference><Reference><Citation>Adams NR, Vasquez YM, Mo Q, Gibbons W, Kovanci E, DeMayo FJ. WNK lysine deficient protein kinase 1 regulates human endometrial stromal cell decidualization, proliferation, and migration in part through mitogen-activated protein kinase 7. Biol Reprod. 2017;97:400&#x2013;12.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6109229</ArticleId><ArticleId IdType="pubmed">29025069</ArticleId></ArticleIdList></Reference><Reference><Citation>Goulmy E. Minor histocompatibility antigens: from transplantation problems to therapy of cancer. Hum Immunol. 2006;67:433&#x2013;8.</Citation><ArticleIdList><ArticleId IdType="pubmed">16728266</ArticleId></ArticleIdList></Reference><Reference><Citation>Akatsuka Y, Morishima Y, Kuzushima K, Kodera Y, Takahashi T. Minor histocompatibility antigens as targets for immunotherapy using allogeneic immune reactions. Cancer Sci. 2007;98:1139&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pubmed">17521316</ArticleId></ArticleIdList></Reference><Reference><Citation>Verdijk RM, Kloosterman A, Pool J, van de Keur M, Naipal AM, van Halteren AG, et al. Pregnancy induces minor histocompatibility antigen-specific cytotoxic T cells: implications for stem cell transplantation and immunotherapy. Blood. 2004;103:1961&#x2013;4.</Citation><ArticleIdList><ArticleId IdType="pubmed">14592836</ArticleId></ArticleIdList></Reference><Reference><Citation>van Halteren AG, Jankowska-Gan E, Joosten A, Blokland E, Pool J, Brand A, et al. Naturally acquired tolerance and sensitization to minor histocompatibility antigens in healthy family members. Blood. 2009;114:2263&#x2013;72.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3402366</ArticleId><ArticleId IdType="pubmed">19506299</ArticleId></ArticleIdList></Reference><Reference><Citation>Linscheid C, Petroff MG. Minor histocompatibility antigens and the maternal immune response to the fetus during pregnancy. Am J Reprod Immunol. 2013;69:304&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4048750</ArticleId><ArticleId IdType="pubmed">23398025</ArticleId></ArticleIdList></Reference><Reference><Citation>Holland OJ, Linscheid C, Hodes HC, Nauser TL, Gilliam M, Stone P, et al. Minor histocompatibility antigens are expressed in syncytiotrophoblast and trophoblast debris: implications for maternal alloreactivity to the fetus. Am J Pathol. 2012;180:256&#x2013;66.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3338347</ArticleId><ArticleId IdType="pubmed">22079431</ArticleId></ArticleIdList></Reference><Reference><Citation>Tong M, Chamley LW. Placental extracellular vesicles and feto-maternal communication. Cold Spring Harb Perspect Med. 2015;5:a023028.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4355256</ArticleId><ArticleId IdType="pubmed">25635060</ArticleId></ArticleIdList></Reference><Reference><Citation>Germain SJ, Sacks GP, Sooranna SR, Sargent IL, Redman CW. Systemic inflammatory priming in normal pregnancy and preeclampsia: the role of circulating syncytiotrophoblast microparticles. J Immunol. 2007;178:5949&#x2013;56.</Citation><ArticleIdList><ArticleId IdType="pubmed">17442979</ArticleId></ArticleIdList></Reference><Reference><Citation>Mistry P, Kaplan MJ. Cell death in the pathogenesis of systemic lupus erythematosus and lupus nephritis. Clin Immunol. 2017;185:59&#x2013;73. doi: 10.1016/j.clim.2016.08.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clim.2016.08.010</ArticleId><ArticleId IdType="pmc">PMC5299061</ArticleId><ArticleId IdType="pubmed">27519955</ArticleId></ArticleIdList></Reference><Reference><Citation>Olson JE, Shu XO, Ross JA, Pendergrass T, Robison LL. Medical record validation of maternally reported birth characteristics and pregnancy-related events: a report from the Children's Cancer Group. Am J Epidemiol. 1997;145:58&#x2013;67.</Citation><ArticleIdList><ArticleId IdType="pubmed">8982023</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomeo CA, Rich-Edwards JW, Michels KB, Berkey CS, Hunter DJ, Frazier AL, et al. Reproducibility and validity of maternal recall of pregnancy-related events. Epidemiology. 1999;10:774&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">10535796</ArticleId></ArticleIdList></Reference><Reference><Citation>Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315&#x2013;24.</Citation><ArticleIdList><ArticleId IdType="pubmed">3358796</ArticleId></ArticleIdList></Reference><Reference><Citation>Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1997;40:1725.</Citation><ArticleIdList><ArticleId IdType="pubmed">9324032</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan EM, Cohen AS, Fries JF, Masi AT, McShane DJ, Rothfield NF, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271&#x2013;7.</Citation><ArticleIdList><ArticleId IdType="pubmed">7138600</ArticleId></ArticleIdList></Reference><Reference><Citation>Triulzi DJ, Kleinman S, Kakaiya RM, Busch MP, Norris PJ, Steele WR, et al. The effect of previous pregnancy and transfusion on HLA alloimmunization in blood donors: implications for a transfusion-related acute lung injury risk reduction strategy. Transfusion. 2009;49:1825&#x2013;35.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2841001</ArticleId><ArticleId IdType="pubmed">19453983</ArticleId></ArticleIdList></Reference><Reference><Citation>Bodian DL, Klein E, Iyer RK, Wong WS, Kothiyal P, Stauffer D. Utility of whole-genome sequencing for detection of newborn screening disorders in a population cohort of 1,696 neonates. Genet Med. 2016;18:221&#x2013;30. doi: 10.1038/gim.2015.111.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/gim.2015.111</ArticleId><ArticleId IdType="pubmed">26334177</ArticleId></ArticleIdList></Reference><Reference><Citation>Jia X, Han B, Onengut-Gumuscu S, Chen WM, Concannon PJ, Rich SS, et al. Imputing amino acid polymorphisms in human leukocyte antigens. PLoS ONE. 2013;8:e64683.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675122</ArticleId><ArticleId IdType="pubmed">23762245</ArticleId></ArticleIdList></Reference><Reference><Citation>Raychaudhuri S, Sandor C, Stahl EA, Freudenberg J, Lee HS, Jia X, et al. Five amino acids in three HLA proteins explain most of the association between MHC and seropositive rheumatoid arthritis. Nat Genet. 2012;44:291&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3288335</ArticleId><ArticleId IdType="pubmed">22286218</ArticleId></ArticleIdList></Reference><Reference><Citation>Oostvogels R, Lokhorst HM, Minnema MC, van Elk M, van den Oudenalder K, Spierings E, et al. Identification of minor histocompatibility antigens based on the 1000 Genomes Project. Haematologica. 2014;99:1854&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4258743</ArticleId><ArticleId IdType="pubmed">25150256</ArticleId></ArticleIdList></Reference><Reference><Citation>Howie BN, Donnelly P, Marchini J. A flexible and accurate genotype imputation method for the next generation of genome-wide association studies. PLoS Genet. 2009;5:e1000529.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2689936</ArticleId><ArticleId IdType="pubmed">19543373</ArticleId></ArticleIdList></Reference><Reference><Citation>Lee SJ, Klein J, Haagenson M, Baxter-Lowe LA, Confer DL, Eapen M, et al. High-resolution donor-recipient HLA matching contributes to the success of unrelated donor marrow transplantation. Blood. 2007;110:4576&#x2013;83.</Citation><ArticleIdList><ArticleId IdType="pubmed">17785583</ArticleId></ArticleIdList></Reference><Reference><Citation>Elsner HA, DeLuca D, Strub J, Blasczyk R. HistoCheck: rating of HLA class I and II mismatches by an internet-based software tool. Bone Marrow Transplant. 2004;33:165&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pubmed">14647261</ArticleId></ArticleIdList></Reference><Reference><Citation>Rothman KJ. No adjustments are needed for multiple comparisons. Epidemiology. 1990;1:43&#x2013;6.</Citation><ArticleIdList><ArticleId IdType="pubmed">2081237</ArticleId></ArticleIdList></Reference><Reference><Citation>Team RC. R: a language and environment for statistical computing. R Foundation for Statistical Computing: Vienna, Austria; 2015.</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>